HALETHORPE, Md., May 20, 2022 /PRNewswire/ — Fzata, Inc., a biotech innovator, is proud to announce that it has been named the winner of the 2022 Mid-Atlantic Innovation Celebration for Biotechnology for its oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. The Company is honored to have been selected for this award from among so many highly innovative c
Every year the event, hosted by Northern Virginia Chamber of Commerce (NOVA) and BigIdea ConnectPreneur, showcases the region’s greatest and most creative minds at work. Innovators can be almost anything, from cutting-edge products that solve business needs to creative shifts that improve employee morale.
Fzata is a near-clinical stage platform biopharmaceutical company in the BioHealth Capital Region. Our vision is to reduce health inequities by expanding patient access to therapeutic biologics with patient friendly oral capsules. BioPYM uses genetically modified live yeast as a ‘micro-factory’ to make recombinant biologics in the gut to target disease biomarkers and modulate gut function….”
Fzata (www.Fzata.com) is a near-clinical stage biopharmaceutical company, developing oral live biologic-based preventive and therapeutic medicines. The Company owns two proprietary platforms: one to generate fully humanized multi-specific antibodies and a second, BioPYM, for localized delivery of recombinant biologic therapeutics to treat gastrointestinal related diseases.
About Northern Virginia Chamhttps://www.prnewswire.com/news-releases/fzata-winner-of-mid-atlantic-innovation-celebration-biotechnology-301552138.html?tc=eml_cleartimeber of Commerce
Founded in 1925 as a Fairfax County-focused business advocacy organization, NOVA is the region’s largest Chamber of Commerce, drawing members and impacting policy across the Greater Washington D.C. Metropolitan Region.” Original story published by Cision PR Newswire.